Nicotine - COVID / SARS / ARDS: Difference between revisions
Jump to navigation
Jump to search
(Added content) |
|||
Line 16: | Line 16: | ||
=Suggested studies to add to this page= | =Suggested studies to add to this page= | ||
===2021: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183099/pdf/main.pdf Transdermal nicotine in non-smokers: a systematic review to design COVID-19 clinical trials]=== | |||
Line 25: | Line 27: | ||
===2020: [https://pubmed.ncbi.nlm.nih.gov/32595653/ Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm]=== | ===2020: [https://pubmed.ncbi.nlm.nih.gov/32595653/ Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm]=== | ||
=Threads about COVID on Twitter by @phil_w888= | =Threads about COVID on Twitter by @phil_w888= |